Anthony D'Adamio - 14 Mar 2025 Form 4 Insider Report for Bioventus Inc. (BVS)

Role
SVP & General Counsel
Signature
/s/ Anthony D'Adamio
Issuer symbol
BVS
Transactions as of
14 Mar 2025
Transactions value $
$0
Form type
4
Filing time
14 Mar 2025, 19:05:56 UTC
Previous filing
20 Feb 2025
Next filing
18 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BVS Class A Common Stock Options Exercise $0 +8.89K +7.52% $0.00 127K 14 Mar 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BVS Restricted Stock Units Options Exercise $0 -8.89K -50% $0.00 8.89K 14 Mar 2025 Class A Common Stock 8.89K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
F2 The original grant of 35,545 RSUs vest in four approximately equal annual installments beginning on March 14, 2023.